|
BRAINSTORM
A
Little Poison Can Be Good For You
The received wisdom about toxins and radiation
may be all wet.
Wednesday,
May 28, 2003 By David Stipp
Toxic-tort lawyers aren't going to like this: Evidence is growing
that most hazardous chemicals, as well as radiation, not only are
harmless at low doses--but may actually do a body good. Scientists
who study this mind-bending effect, called hormesis, have quietly
marshaled a wealth of examples showing that it's real. And it
appears to be more the rule than the exception--long-ignored signs
of the phenomenon have been unearthed in hundreds of studies on
everything from toxic heavy metals to dread carcinogens like dioxin.
Hormesis is pure poison to the conventional wisdom in toxicology.
It contradicts the idea that carcinogenic chemicals pose risk at any
dose, no matter how low. That concept has dominated regulatory
thinking since the 1970s, helping motivate billions of dollars of
cleanups and countless lawsuits involving low-dose exposures. And if
hormesis experts are right, the time-honored method for quantifying
toxic risks at low doses--the levels typically encountered outside
the lab--has all the accuracy of a fun-house mirror.
Here's the standard technique: Lab animals are exposed to
megadoses of a toxin, causing pronounced effects that are readily
measured. That yields guesstimates of the human effects at
megalevels. To estimate the risk at low doses, regulators assume
that the toxic effects fall in a straight line with the dose. Tumor
incidence in rats vs. doses of saccharin, for instance, would be
graphed on X and Y axes as a straight line. The handy line shows the
purported risk at doses down to zero.
But scientists who go to the trouble of measuring actual toxic
effects at low levels often observe a J-shaped "dose response" curve
instead of a straight line. That means the risks many toxins pose at
real-world levels have probably been exaggerated. The J-curve also
suggests an idea that, at first blush, seems daft: Policies that
foster small exposures to toxins might be better for public health
than ones aimed at eliminating them.
Don't mess with this radical notion at home. On second thought,
it may well be too late: Consider the toxins you've probably already
taken at low doses in order to get their hormetic effects: a kidney
poison known as vitamin D, a neurotoxin called caffeine, and that
edifying solvent and fuel additive, ethyl alcohol--it seems that
people who regularly imbibe small doses of alcohol, whether in red
wine or other drinks, live longer.
Exercise fits the J-curve too. Moderate workouts are plainly
beneficial--they can boost the immune system and lower the risk of
heart disease. But overdoing it can suppress immune function and
deplete internal stores of antioxidants, potentially leading to
tissue damage from "free radicals." (Free radicals are highly
reactive molecules generated in cells as they burn
fuel--antioxidants neutralize their destructive power.)
To hormesis researchers, the rising interest in toxins' yin-yang
effects seems like the end of 70 years of mass amnesia. Before 1930
the idea that low doses of poisons could be invigorating was
mainstream science. Researchers reported that lightly dousing
bacteria with germicides stimulated their growth, that a little
arsenic revved up yeast metabolism, and that patients with bacterial
infections benefited from low doses of X-rays.
Then quacks gave hormesis a bad name. It became associated with
homeopathy, the bogus idea that diseases can be treated with tiny
traces of toxins. (Homeopaths endorse much smaller doses than those
that typically trigger hormesis.) Worse, radium-laced elixirs hit
the market. Citing studies on the positive effects of low-dose
radiation, makers of potions touted them as energizing cure-alls. In
1932 came a high-profile tragedy: Steel millionaire and playboy Eben
Byers, a heavy user of an elixir called Radithor, suffered massive
bone deterioration and died at 51 from radiation poisoning. Years
ago the Wall Street Journal recounted the grisly case under a
particularly memorable headline: The Radium Water Worked Fine Until
His Jaw Came Off.
Soon after, hormesis went the way of patent medicines. But the
effect continued to turn up in toxicology research, generating
little waves of interest. In 1990, University of Massachusetts
public-health professor Ed Calabrese launched a hormesis revival by
forming an international body to foster research on the phenomenon.
Calabrese had stumbled onto hormesis as an undergraduate in the
1960s while studying the effects of a growth-inhibiting chemical on
peppermint plants--they unexpectedly grew faster on low doses. He
regarded the finding as a minor anomaly until the mid-1980s, when he
heard that low doses of radiation had a similar effect. Suspecting a
broad phenomenon was at work, he zeroed in on it. By the late 1990s
he and colleague Linda A. Baldwin had ferreted out an impressive set
of hormetic effects from the scientific literature--everything from
the stimulation of tumor cells by low doses of a cancer drug called
suramin to the speeding of insect development by low levels of
cyanide.
Their work began ruffling feathers. A long-standing objection is
that the definition of hormesis is hazy. Many toxicologists argue
that the term should apply only to cases in which a known mechanism
can explain the J-curve. For instance, a toxin might stimulate a
cellular defense system that "overshoots" at low doses, affording
lingering resistance to injury. Higher doses overwhelm the system,
producing the J-shaped response.
This strict definition offers a major plus: It grounds hormesis
in familiar science, making its radical implications plausible.
Scientists have long known, for example, that zapping insects with
mild doses of radiation revs up their cells' inner fix-it systems,
which repair DNA and other molecules damaged by the rays. This
hormetic response turns them into superbugs, hardened to larger
doses that would otherwise kill. They live longer than unradiated
insects too.
But Calabrese, the hormesis revolution's George Washington,
prefers a more inclusive definition: Hormesis, he says, is defined
by low-level stimulation and high-level inhibition--irrespective of
underlying mechanisms. Thus, alcohol is hormetic in his view because
it boosts longevity at low doses and lessens it at high ones, even
though the mechanism by which it does so isn't understood.
Given all the hot buttons hormesis hits, you'd think it would
have spawned endless vitriolic disputes. Instead it has mainly
generated thoughtful debates. Credit for the civility goes mainly to
Calabrese, who sees polarizing clashes as a waste. A wiry,
soft-spoken bicycling enthusiast with tousled gray locks, Calabrese,
57, is the most disarming of contrarians. At a hormesis meeting he
organized in 2000, a prominent colleague stood up and delivered a
biting critique: Despite assembling many examples of hormesis, he
complained, Calabrese had failed to establish whether a significant
proportion of toxins manifest the effect. "I had to admit in front
of everyone that he was right," says Calabrese. "After I licked my
wounds, I called him up" and enlisted his help in designing a study
to address the issue.
For the study, which turned out to be a landmark work, Calabrese
and Baldwin spent a year poring over some 21,000 papers on
pesticides, metals, industrial wastes, and other toxins. Few of the
studies included enough data at low doses to show whether hormesis
had occurred. Of the ones that did, though, hormetic responses were
seen 2.5 times more often than responses going the other way.
That compelling result, detailed this year in Toxicological
Sciences, put hormesis firmly on the map. Now Calabrese argues that
regulators should use the J-curve, instead of straight lines, to
estimate low-dose effects of toxins. That change would have
momentous policy implications--and probably won't happen soon. But
Calabrese sees many ways hormesis might be applied before it gains
greater acceptance. For instance, it might well make sense to give
low, protective doses of X-rays to people facing subsequent exposure
to high doses of radiation, such as rescue teams coping with the
aftermath of a terrorist "dirty bomb." The medical world probably
isn't ready to entertain this far-out concept. But Tom Ridge might
be. |